All news articles for October 2014

Movers and shakers in outsourcing

People on the Move

Movers and shakers in outsourcing

By Fiona Barry

This week's round-up of who's going places in contract research, manufacturing and services.

The funds will help to grow the company further

CDMO Paragon Bioservices raises $13m in financing

By Zachary Brennan

Contract research and manufacturing organization Paragon Bioservices has raised $13m in a Series A Preferred Stock financing, led by NewSpring Capital and Camden Partners, to continue to grow the company.

INC follows peers PRA Health Sciences and Quintiles with its IPO

INC Research sets pricing for IPO at $150m

By Zachary Brennan

The Raleigh, North Carolina-based CRO INC Research plans to raise about $150m in its initial public offering via about 8.1m shares at a price range of $17 to $20 per share. 

Sponsors continue to rely on a mix of outsourcing models.

Strategic partnerships yet to fully catch on, Tufts report finds

By Zachary Brennan

Although a growing number of sponsors and CROs have managed strategic relationships for as many as five years, sponsors still rely on a mix of outsourcing approaches to tackle their clinical programs, according to a new report.

Forum to help CROs interact with TransCelerate

Forum to help CROs interact with TransCelerate

By Zachary Brennan

The Association of Clinical Research Organizations (ACRO) on Monday announced plans to create a CRO Forum in order to provide a formal mechanism for the CRO industry to offer insight into the work of industry group TransCelerate BioPharma.

People on the Move

People on the Move

People on the Move

By Fiona Barry

Former employees of Procter & Gamble, Merck & Co. and Bristol Myers Squibb have all found new homes in the pharma industry in this week's People column.

Mouse model firm Crown builds oncology centre

Mouse model firm Crown builds oncology centre

By Fiona BARRY

Animal-model contract research organisation (CRO) Crown Bioscience will open a research centre in North Carolina, combining expanded oncology services with its existing cardiovascular and metabolic offerings.

Francis Collins' comments provoked a backlash

NIH: without budget cuts, we’d have Ebola vaccine

By Fiona Barry

The head of the US National Institutes of Health has said the organisation would have developed a finished Ebola vaccine by now if its funding had not been slashed over the last decade.

European Parliament in Strasbourg, France

EMA tells us it looks forward to continuing close relationship with DG SANCO

Juncked: Plan to move EMA from DG Health to DG Enterprise is abandoned

By Gareth Macdonald

DG Health will keep responsibility for the EMA according to European Commission President-elect Jean-Claude Juncker, who confirmed plans to hand the agency to DG Enterprise have been abandoned.